KR20130132375A - 신장 증후군 및 관련 질환을 치료하는 방법 - Google Patents

신장 증후군 및 관련 질환을 치료하는 방법 Download PDF

Info

Publication number
KR20130132375A
KR20130132375A KR1020137000446A KR20137000446A KR20130132375A KR 20130132375 A KR20130132375 A KR 20130132375A KR 1020137000446 A KR1020137000446 A KR 1020137000446A KR 20137000446 A KR20137000446 A KR 20137000446A KR 20130132375 A KR20130132375 A KR 20130132375A
Authority
KR
South Korea
Prior art keywords
angptl4
nephrotic syndrome
leu
polypeptide
angptl4 polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020137000446A
Other languages
English (en)
Korean (ko)
Inventor
슈만트 추그흐
Original Assignee
더 유에이비 리서치 파운데이션
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 더 유에이비 리서치 파운데이션 filed Critical 더 유에이비 리서치 파운데이션
Publication of KR20130132375A publication Critical patent/KR20130132375A/ko
Ceased legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
KR1020137000446A 2010-06-05 2011-06-06 신장 증후군 및 관련 질환을 치료하는 방법 Ceased KR20130132375A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US35186610P 2010-06-05 2010-06-05
US61/351,866 2010-06-05
PCT/US2011/039255 WO2011153525A2 (en) 2010-06-05 2011-06-06 Methods for treatment of nephrotic syndrome and related conditions

Publications (1)

Publication Number Publication Date
KR20130132375A true KR20130132375A (ko) 2013-12-04

Family

ID=45067339

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020137000446A Ceased KR20130132375A (ko) 2010-06-05 2011-06-06 신장 증후군 및 관련 질환을 치료하는 방법

Country Status (12)

Country Link
EP (2) EP2575858B1 (enExample)
JP (1) JP5904560B2 (enExample)
KR (1) KR20130132375A (enExample)
CN (2) CN103140234B (enExample)
AU (1) AU2011261196B2 (enExample)
CA (1) CA2801579C (enExample)
DK (1) DK2575858T3 (enExample)
ES (1) ES2663096T3 (enExample)
NO (1) NO2575858T3 (enExample)
PL (1) PL2575858T3 (enExample)
PT (1) PT2575858T (enExample)
WO (1) WO2011153525A2 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110301103A1 (en) 2010-06-05 2011-12-08 Chugh Sumant S Methods of Treatment
US9139629B2 (en) 2010-06-05 2015-09-22 The Uab Research Foundation Methods for treatment of nephrotic syndrome and related conditions
JP2016516726A (ja) * 2013-03-15 2016-06-09 ザ・ユー・エイ・ビー・リサーチ・フアンデーシヨン ネフローゼ症候群及び関連状態の治療方法
WO2015107501A1 (en) * 2014-01-20 2015-07-23 Ghiggeri Gian Marco In vitro method for predicting, diagnosing and monitoring in therapeutic follow up lupus nephritis
CN114934021B (zh) * 2022-04-21 2023-08-08 复旦大学附属儿科医院 一种Angptl3敲除的鼠永生化足细胞系及其应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001005825A2 (en) * 1999-07-16 2001-01-25 Hyseq, Inc. Nucleic acid sequences encoding putative angiopoietin proteins
JP2005080508A (ja) * 2003-09-04 2005-03-31 Sankyo Co Ltd 脂質代謝改善剤の試験方法
CN1980686A (zh) * 2004-04-05 2007-06-13 安斯泰来制药有限公司 抗肥胖药
MX2007000783A (es) * 2004-07-20 2007-04-09 Genentech Inc Inhibidores de proteina angiopoietina tipo 4, combinaciones y su uso.
EP2007899B1 (en) * 2006-03-20 2017-06-07 Celldex Therapeutics, Inc. Antibodies directed to angiopoietin-like protein 4 and uses thereof
CA2903133C (en) * 2007-05-31 2021-10-19 Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services National Institutes Of Health N-acetyl mannosamine or derivatives thereof for use in treating a kidney disorder in a mammal

Also Published As

Publication number Publication date
JP5904560B2 (ja) 2016-04-13
CA2801579C (en) 2021-12-14
JP2013528625A (ja) 2013-07-11
PL2575858T3 (pl) 2018-08-31
CN103140234B (zh) 2016-12-21
ES2663096T3 (es) 2018-04-11
CA2801579A1 (en) 2011-12-08
HK1252916A1 (en) 2019-06-06
AU2011261196A1 (en) 2013-01-10
WO2011153525A2 (en) 2011-12-08
EP3318269B1 (en) 2024-03-13
NO2575858T3 (enExample) 2018-05-19
EP2575858A4 (en) 2014-01-01
EP2575858A2 (en) 2013-04-10
CN103140234A (zh) 2013-06-05
AU2011261196B2 (en) 2015-05-21
EP3318269A1 (en) 2018-05-09
WO2011153525A9 (en) 2012-04-19
DK2575858T3 (en) 2018-03-12
EP3318269C0 (en) 2024-03-13
PT2575858T (pt) 2018-03-22
CN107412729A (zh) 2017-12-01
EP2575858B1 (en) 2017-12-20

Similar Documents

Publication Publication Date Title
EP2328917B1 (en) Neuronal viability factor and use thereof
KR20130132375A (ko) 신장 증후군 및 관련 질환을 치료하는 방법
KR20180009382A (ko) 치료 방법
KR102221041B1 (ko) 신증후군 및 관련 병태의 치료 방법
US11866468B2 (en) Methods for treatment of nephrotic syndrome and related conditions
US9475850B2 (en) Methods for treatment of nephrotic syndrome and related conditions
HK1252916B (en) Use of an angiopoietin-like 4 (angptl4) polypeptide in the manufacture of a medicament for the treatment of proteinuria.
HK1220213B (en) Methods for treatment of nephrotic syndrome and related conditions
KR20140121088A (ko) 신규한 소포체 막투과성 단백질

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20130107

Patent event code: PA01051R01D

Comment text: International Patent Application

AMND Amendment
PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20160607

Comment text: Request for Examination of Application

PN2301 Change of applicant

Patent event date: 20160927

Comment text: Notification of Change of Applicant

Patent event code: PN23011R01D

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20170719

Patent event code: PE09021S01D

AMND Amendment
E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20180123

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20170719

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I

AMND Amendment
PX0901 Re-examination

Patent event code: PX09011S01I

Patent event date: 20180123

Comment text: Decision to Refuse Application

Patent event code: PX09012R01I

Patent event date: 20170918

Comment text: Amendment to Specification, etc.

Patent event code: PX09012R01I

Patent event date: 20130118

Comment text: Amendment to Specification, etc.

PX0601 Decision of rejection after re-examination

Comment text: Decision to Refuse Application

Patent event code: PX06014S01D

Patent event date: 20180313

Comment text: Amendment to Specification, etc.

Patent event code: PX06012R01I

Patent event date: 20180222

Comment text: Decision to Refuse Application

Patent event code: PX06011S01I

Patent event date: 20180123

Comment text: Amendment to Specification, etc.

Patent event code: PX06012R01I

Patent event date: 20170918

Comment text: Notification of reason for refusal

Patent event code: PX06013S01I

Patent event date: 20170719

Comment text: Amendment to Specification, etc.

Patent event code: PX06012R01I

Patent event date: 20130118